Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 65
- 較 2022 年第 2 季 −34
- 總值
- $2.00 億
- 較 2022 年第 2 季 −$4,085 萬 (−16.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 978,783 | $1,756 萬 | 8.8% | +929,684+1,893.5% | 加碼 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 2,131,147 | $1,428 萬 | 7.1% | +76,545+3.7% | 加碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 231,181 | $1,364 萬 | 6.8% | +231,181 | 新進 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 492,275 | $910.7 萬 | 4.5% | +492,275 | 新進 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 850,134 | $897.7 萬 | 4.5% | −168,193−16.5% | 減碼 | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 317,476 | $892.4 萬 | 4.5% | −220,482−41.0% | 減碼 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 855,616 | $786.3 萬 | 3.9% | −523,806−38.0% | 減碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 610,407 | $731.3 萬 | 3.7% | −389,980−39.0% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 699,440 | $632.2 萬 | 3.2% | +107,317+18.1% | 加碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 728,586 | $627.3 萬 | 3.1% | −679,530−48.3% | 減碼 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 157,805 | $618.0 萬 | 3.1% | +157,805 | 新進 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 472,054 | $602.8 萬 | 3.0% | −425,305−47.4% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 160,486 | $579.4 萬 | 2.9% | −78,955−33.0% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 904,119 | $532.6 萬 | 2.7% | +204,119+29.2% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 325,000 | $531.7 萬 | 2.7% | +325,000 | 新進 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 178,100 | $503.3 萬 | 2.5% | +178,100 | 新進 | 歷史 |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,765,530 | $461.8 萬 | 2.3% | −23,323−0.8% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 74,219 | $459.3 萬 | 2.3% | −85,897−53.6% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 811,700 | $452.9 萬 | 2.3% | +811,700 | 新進 | 歷史 |
| ARDXArdelyx, Inc. | COM | 3,178,825 | $378.4 萬 | 1.9% | +1,498,273+89.2% | 加碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 350,000 | $351.1 萬 | 1.8% | +350,000 | 新進 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 450,406 | $348.2 萬 | 1.7% | +450,406 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 200,000 | $331.6 萬 | 1.7% | +200,000 | 新進 | 歷史 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 96,462 | $317.1 萬 | 1.6% | +96,462 | 新進 | – |
| SCPHscPharmaceuticals Inc. | COM | 479,383 | $312.6 萬 | 1.6% | −404,625−45.8% | 減碼 | 歷史 |
| BLUEbluebird bio, Inc. | COM | 462,628 | $292.8 萬 | 1.5% | +462,628 | 新進 | 歷史 |
| BIIBBiogen Inc. | COM | 10,962 | $292.6 萬 | 1.5% | +9,840+877.0% | 加碼 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 100,000 | $270.0 萬 | 1.3% | +100,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 162,766 | $242.9 萬 | 1.2% | −87,234−34.9% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 16,809 | $185.8 萬 | 0.9% | −8,191−32.8% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 343,685 | $172.2 萬 | 0.9% | −3,653−1.1% | 減碼 | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 45,100 | $148.1 萬 | 0.7% | +45,100 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 463,156 | $126.0 萬 | 0.6% | −372,119−44.6% | 減碼 | 歷史 |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 85,200 | $118.9 萬 | 0.6% | −19,800−18.9% | 減碼 | 歷史 |
| ETNB89bio, Inc. | COM | 200,000 | $115.8 萬 | 0.6% | +200,000 | 新進 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 265,000 | $109.9 萬 | 0.5% | +265,000 | 新進 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 568,612 | $97.3 萬 | 0.5% | −1,111,136−66.1% | 減碼 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 131,310 | $84.3 萬 | 0.4% | −409,314−75.7% | 減碼 | 歷史 |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 189,935 | $83.9 萬 | 0.4% | −63,497−25.1% | 減碼 | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 136,059 | $81.5 萬 | 0.4% | −517,389−79.2% | 減碼 | 歷史 |
| RCORRenovacor, Inc. | COM | 288,119 | $72.5 萬 | 0.4% | −5,164−1.8% | 減碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 221,830 | $61.2 萬 | 0.3% | −140,707−38.8% | 減碼 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 245,896 | $61.2 萬 | 0.3% | −22,208−8.3% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 2,800 | $56.0 萬 | 0.3% | −58,437−95.4% | 減碼 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 188,664 | $55.8 萬 | 0.3% | −69,189−26.8% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 260,087 | $55.6 萬 | 0.3% | −62,130−19.3% | 減碼 | 歷史 |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 448,101 | $53.7 萬 | 0.3% | −75,247−14.4% | 減碼 | – |
| OKUROnKure Therapeutics, Inc. | COM | 155,819 | $52.1 萬 | 0.3% | −29,778−16.0% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 49,031 | $49.0 萬 | 0.2% | −108,159−68.8% | 減碼 | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 156,203 | $43.7 萬 | 0.2% | −24,996−13.8% | 減碼 | 歷史 |
| CLVSClovis Oncology, Inc. | COM | 361,518 | $43.0 萬 | 0.2% | −60,821−14.4% | 減碼 | 歷史 |
| FNCHFinch Therapeutics Group, Inc. | COM | 237,553 | $39.7 萬 | 0.2% | −92,970−28.1% | 減碼 | 歷史 |
| SYBXSynlogic, Inc. | COM | 306,757 | $29.2 萬 | 0.1% | −167,603−35.3% | 減碼 | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | ADS | 219,501 | $28.3 萬 | 0.1% | −458,358−67.6% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 315,131 | $19.3 萬 | 0.1% | +15,131+5.0% | 加碼 | 歷史 |
| ARK Innovation ETF00214Q104 | ETF | 4,519 | $17.1 萬 | 0.1% | +4,519 | 新進 | – |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 820,455 | $14.6 萬 | 0.1% | −150,292−15.5% | 減碼 | – |
| Stealth Biotherapeutics Corp85789A105 | SPONSORED ADS | 435,516 | $13.4 萬 | 0.1% | −66,320−13.2% | 減碼 | – |
| CABACabaletta Bio, Inc. | COM | 168,623 | $10.9 萬 | 0.1% | −775,808−82.1% | 減碼 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 4,064 | $10.2 萬 | 0.1% | −16,741−80.5% | 減碼 | 歷史 |
| SPPISpectrum Pharmaceuticals Inc | COM | 176,980 | $7.60 萬 | <0.1% | +176,980 | 新進 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 397,168 | $6.60 萬 | <0.1% | −465,359−54.0% | 減碼 | 歷史 |
| IVAInventiva S.A. | ADS | 13,236 | $4.80 萬 | <0.1% | −2,343−15.0% | 減碼 | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 3,019 | $2,000 | <0.1% | +3,019 | 新進 | – |
| KDNYChinook Therapeutics, Inc. | COM | 283,464 | $0 | 0.0% | −48,831−14.7% | 減碼 | 歷史 |
選擇權（31 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| RLMDRelmada Therapeutics, Inc. | COM | $2,870 萬 | $2,870 萬 |
| BIIBBiogen Inc. | COM | $1,420 萬 | $1,883 萬 |
| DICEDICE Therapeutics, Inc. | COM | $1,022 萬 | $1,519 萬 |
| SPYSPDR S&P 500 ETF Trust | ETF | $2,143 萬 | – |
| SGENSeagen Inc. | COM | – | $2,053 萬 |
| AXSMAxsome Therapeutics, Inc. | COM | $1,819 萬 | – |
| TCDATricida, Inc. | COM | $762.8 萬 | $605.4 萬 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $1,190 萬 | – |
| ALTAltimmune, Inc. | COM NEW | – | $1,076 萬 |
| RXDXPrometheus Biosciences, Inc. | COM | – | $1,050 萬 |
| SRPTSarepta Therapeutics, Inc. | COM | – | $941.8 萬 |
| ISEEIVERIC bio, Inc. | COM | – | $785.6 萬 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $703.7 萬 |
| KRYSKrystal Biotech, Inc. | COM | $663.5 萬 | – |
| GOSSGossamer Bio, Inc. | COM | $20.9 萬 | $630.8 萬 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $526.7 萬 |
| MISTMilestone Pharmaceuticals Inc. | COM | $310.7 萬 | $165.7 萬 |
| STOKStoke Therapeutics, Inc. | COM | $473.4 萬 | – |
| ARVNArvinas, Inc. | COM | – | $445.0 萬 |
| PRTAProthena Corp Public Ltd Co | SHS | – | $405.0 萬 |
| RETAReata Pharmaceuticals Inc | CL A | $46.3 萬 | $347.0 萬 |
| STSASatsuma Pharmaceuticals, Inc. | COM | – | $240.0 萬 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | – | $226.8 萬 |
| INSMINSMED Inc | COM PAR $.01 | – | $215.4 萬 |
| CLNNClene Inc. | COMMON STOCK | $49.6 萬 | $90.3 萬 |
| AKROAkero Therapeutics, Inc. | COM | – | $139.2 萬 |
| ESPREsperion Therapeutics, Inc. | COM | – | $133.9 萬 |
| GERNGeron Corp | COM | – | $117.0 萬 |
| Bellus Health Inc New07987C204 | COM NEW | – | $90.0 萬 |
| DSGNDesign Therapeutics, Inc. | COM | $81.1 萬 | – |
| PRAXPraxis Precision Medicines, Inc. | COM | – | $16.8 萬 |
2022 年第 2 季之後清倉（52 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| KRTXKaruna Therapeutics, Inc. | COM | 100,000 | $1,265 萬 | 5.2% | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 40,000 | $1,127 萬 | 4.7% | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 40,000 | $942.6 萬 | 3.9% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 60,000 | $497.2 萬 | 2.1% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 225,991 | $491.8 萬 | 2.0% | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 86,865 | $483.0 萬 | 2.0% | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 246,554 | $475.0 萬 | 2.0% | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 86,035 | $419.6 萬 | 1.7% | 歷史 |
| PFEPfizer Inc | Stock | 80,000 | $419.4 萬 | 1.7% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 38,600 | $376.3 萬 | 1.6% | 歷史 |
| Kraneshares Trust500767306 | CSI CHI INTERNET | 100,000 | $327.7 萬 | 1.4% | – |
| INSMINSMED Inc | COM PAR $.01 | 125,000 | $246.5 萬 | 1.0% | 歷史 |
| ACETAdicet Bio, Inc. | COM | 143,214 | $209.1 萬 | 0.9% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 41,900 | $189.4 萬 | 0.8% | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 375,000 | $149.6 萬 | 0.6% | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 316,939 | $140.1 萬 | 0.6% | 歷史 |
| NTBLNotable Labs, Ltd. | COM | 830,007 | $133.7 萬 | 0.6% | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 412,343 | $127.4 萬 | 0.5% | 歷史 |
| MRUSMerus N.V. | COM | 53,703 | $121.6 萬 | 0.5% | 歷史 |
| CMRXChimerix Inc | COM | 441,203 | $91.7 萬 | 0.4% | 歷史 |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 702,773 | $79.4 萬 | 0.3% | 歷史 |
| AYLAOld Ayala, Inc | COM | 697,316 | $75.9 萬 | 0.3% | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 2,892,316 | $75.2 萬 | 0.3% | 歷史 |
| IRONDisc Medicine, Inc. | COM | 443,096 | $74.9 萬 | 0.3% | 歷史 |
| PRDSPardes Biosciences, Inc. | COM | 223,934 | $68.7 萬 | 0.3% | 歷史 |
| TAOXTAO Synergies Inc. | COM NEW | 121,191 | $61.4 萬 | 0.3% | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 49,372 | $56.1 萬 | 0.2% | 歷史 |
| EOLSEvolus, Inc. | COM | 45,516 | $52.9 萬 | 0.2% | 歷史 |
| CASICASI Pharmaceuticals, Inc (DE) | COM NEW | 132,014 | $37.8 萬 | 0.2% | 歷史 |
| NXTCNextCure, Inc. | COM | 71,435 | $33.6 萬 | 0.1% | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 98,039 | $31.8 萬 | 0.1% | 歷史 |
| ZLABZai Lab Ltd | ADR | 81,843 | $27.8 萬 | 0.1% | 歷史 |
| VSTMVerastem, Inc. | COM | 228,023 | $26.5 萬 | 0.1% | 歷史 |
| Immunoprecise Antibodies Ltd45257F200 | COM NEW | 61,433 | $23.7 萬 | 0.1% | – |
| HEPAHepion Pharmaceuticals, Inc. | COM | 410,189 | $23.5 萬 | 0.1% | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 105,341 | $21.7 萬 | 0.1% | 歷史 |
| IMUXImmunic, Inc. | COM | 61,500 | $21.4 萬 | 0.1% | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 615,856 | $19.9 萬 | 0.1% | 歷史 |
| KAKineta, Inc. | COM | 104,392 | $19.0 萬 | 0.1% | 歷史 |
| CLNNClene Inc. | COMMON STOCK | 70,000 | $17.7 萬 | 0.1% | 歷史 |
| QCLSQ/C Technologies, Inc. | COM | 81,089 | $17.6 萬 | 0.1% | 歷史 |
| MBIOMustang Bio, Inc. | COM | 246,824 | $14.5 萬 | 0.1% | 歷史 |
| TPSTTempest Therapeutics, Inc. | COM | 61,827 | $13.2 萬 | 0.1% | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 104,741 | $11.3 萬 | <0.1% | – |
| LRMRLarimar Therapeutics, Inc. | COM | 51,606 | $10.0 萬 | <0.1% | 歷史 |
| DRUGBright Minds Biosciences Inc. | COM | 105,958 | $8.60 萬 | <0.1% | 歷史 |
| DFTXDefinium Therapeutics, Inc. | COM | 105,958 | $6.80 萬 | <0.1% | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 26,831 | $5.90 萬 | <0.1% | 歷史 |
| ENVBEnveric Biosciences, Inc. | COM NEW | 223,834 | $4.80 萬 | <0.1% | 歷史 |
| CYTOFAltamira Therapeutics Ltd. | SHS | 75,000 | $3.60 萬 | <0.1% | 歷史 |
| BXRXBaudax Bio, Inc. | COM NEW | 2,966 | $3,000 | <0.1% | 歷史 |
| OTICOtonomy, Inc. | COM | 180 | $0 | 0.0% | 歷史 |